Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase

Abstract

IT is generally believed that noradrenaline synthesis in postganglionic sympathetic nerves can be suppressed by drugs which inhibit the activities of tyrosine hydroxylase or dopamine β-oxidase1,2, but not by inhibition of aromatic 1-amino acid decarboxylase (AAAD; dopa decarboxylase). We present here evidence that the administration to rats of carbidopa (MK-486; α-methyl-L-dopa-hydrazine), a peripherally acting inhibitor of AAAD3, not only blocks the decarboxylation of exogenous L-dopa (for example, in capillary endothelia within the central nervous system, liver, and kidney4,5), but also suppresses the decarboxylation of endogenous dopa formed from 3H-tyrosine within cardiac sympathetic nerve terminals. As a consequence, the drug inhibits noradrenaline synthesis in this tissue.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Costa, E., et al., Pharmac. Rev., 24, 167–190 (1972).

    CAS  Google Scholar 

  2. Weiner, N., Cloutier, G., Bjur, R., and Pfeffer, R. I., Pharmac. Rev., 24, 203–221 (1972).

    CAS  Google Scholar 

  3. Lotti, V. J., and Porter, C. C., J. Pharmac. exp. Ther., 172, 406–415 (1970).

    CAS  Google Scholar 

  4. Bartholini, G., and Pletscher, A., J. pharm. Pharmac., 21, 323–324 (1969).

    Article  CAS  Google Scholar 

  5. Anden, N.-E., Engel, J., and Rubenson, A., Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak., 273, 11–26 (1972).

    Article  CAS  Google Scholar 

  6. Waalkes, T. P., and Udenfriend, S., J. Lab. clin. Med., 50, 733–736 (1957).

    CAS  PubMed  Google Scholar 

  7. Kehr, W., Carlsson, A., and Lindqvist, M., Naunym-Schmiedeberg's Arch. exp. Path. Pharmak., 274, 273–280 (1972).

    Article  CAS  Google Scholar 

  8. Anton, A. H., and Sayre, D. F., J. Pharmac. exp. Ther., 138, 360–375 (1962).

    CAS  Google Scholar 

  9. Udenfriend, S., Zaltzman-Nirenberg, P., Gordon, R., and Spector, S., Molec. Pharmac., 2, 95–105 (1966).

    CAS  Google Scholar 

  10. Vickers, A., et al., Drug Metab. Dispos., 2, 9–22 (1974).

    CAS  PubMed  Google Scholar 

  11. Scriabine, A., Ludden, C. T., Stone, C. A., Wurtman, R. J., and Watkins, C. J., Clin. Sci. molec. Med. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WURTMAN, R., WATKINS, C. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase. Nature 265, 79–80 (1977). https://doi.org/10.1038/265079a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/265079a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing